TCERG1 Regulates Alternative Splicing of the Bcl-x Gene by Modulating the Rate of RNA Polymerase II Transcription

REFERENCES

• Alexander RD, Innocente SA, Barrass JD, Beggs JD. 2010. Splicing-dependent RNA polymerase pausing in yeast. Mol. Cell 40:582–593.
   PubMed Web of Science ®Google Scholar
• Allo M, et al. 2009. Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol. 16:717–724.
   PubMed Web of Science ®Google Scholar
• Boise LH, et al. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608.
   PubMed Web of Science ®Google Scholar
• Bourquin JP, et al. 1997. A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II. Nucleic Acids Res. 25:2055–2061.
   PubMed Web of Science ®Google Scholar
• Caceres JF, Kornblihtt AR. 2002. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18:186–193.
   PubMed Web of Science ®Google Scholar
• Carrillo Oesterreich F, Preibisch S, Neugebauer KM. 2010. Global analysis of nascent RNA reveals transcriptional pausing in terminal exons. Mol. Cell 40:571–581.
   PubMed Web of Science ®Google Scholar
• Carty SM, Goldstrohm AC, Suñé C, Garcia-Blanco MA, Greenleaf AL. 2000. Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 97:9015–9020.
   PubMed Web of Science ®Google Scholar
• Chapman RD, Palancade B, Lang A, Bensaude O, Eick D. 2004. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability. Nucleic Acids Res. 32:35–44.
   PubMed Web of Science ®Google Scholar
• Chavez S, Garcia-Rubio M, Prado F, Aguilera A. 2001. Hpr1 is preferentially required for transcription of either long or G+C-rich DNA sequences in Saccharomyces cerevisiae. Mol. Cell. Biol. 21:7054–7064.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chafin D, Price DH, Greenleaf AL. 1996. Drosophila RNA polymerase II mutants that affect transcription elongation. J. Biol. Chem. 271:5993–5999.
   PubMed Web of Science ®Google Scholar
• Cheng D, Cote J, Shaaban S, Bedford MT. 2007. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 25:71–83.
   PubMed Web of Science ®Google Scholar
• Coulter DE, Greenleaf AL. 1985. A mutation in the largest subunit of RNA polymerase II alters RNA chain elongation in vitro. J. Biol. Chem. 260:13190–13198.
   PubMedGoogle Scholar
• Damgaard CK, et al. 2008. A 5′ splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol. Cell 29:271–278.
   PubMed Web of Science ®Google Scholar
• Deckert J, et al. 2006. Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions. Mol. Cell. Biol. 26:5528–5543.
   PubMed Web of Science ®Google Scholar
• de la Mata M, Kornblihtt AR. 2006. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat. Struct. Mol. Biol. 13:973–980.
   PubMed Web of Science ®Google Scholar
• de la Mata M, et al. 2003. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12:525–532.
   PubMed Web of Science ®Google Scholar
• Eperon LP, Graham IR, Griffiths AD, Eperon IC. 1988. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase? Cell 54:393–401.
   PubMed Web of Science ®Google Scholar
• Furger A, O'Sullivan JM, Binnie A, Lee BA, Proudfoot NJ. 2002. Promoter proximal splice sites enhance transcription. Genes Dev. 16:2792–2799.
   PubMed Web of Science ®Google Scholar
• Garcia-Blanco MA, Baraniak AP, Lasda EL. 2004. Alternative splicing in disease and therapy. Nat. Biotechnol. 22:535–546.
   PubMed Web of Science ®Google Scholar
• Garneau D, Revil T, Fisette JF, Chabot B. 2005. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 280:22641–22650.
   PubMed Web of Science ®Google Scholar
• Gerber HP, et al. 1995. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature 374:660–662.
   PubMed Web of Science ®Google Scholar
• Gilchrist DA, et al. 2010. Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation. Cell 143:540–551.
   PubMedGoogle Scholar
• Goldstrohm AC, Albrecht TR, Suñé C, Bedford MT, Garcia-Blanco MA. 2001. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol. Cell. Biol. 21:7617–7628.
   PubMed Web of Science ®Google Scholar
• Goldstrohm AC, Greenleaf AL, Garcia-Blanco MA. 2001. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277:31–47.
   PubMed Web of Science ®Google Scholar
• Hendrix DA, Hong JW, Zeitlinger J, Rokhsar DS, Levine MS. 2008. Promoter elements associated with RNA Pol II stalling in the Drosophila embryo. Proc. Natl. Acad. Sci. U. S. A. 105:7762–7767.
   PubMed Web of Science ®Google Scholar
• Howe KJ, Kane CM, Ares MJr. 2003. Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae. RNA 9:993–1006.
   PubMed Web of Science ®Google Scholar
• Kadener S, et al. 2001. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J. 20:5759–5768.
   PubMed Web of Science ®Google Scholar
• Kim E, Du L, Bregman DB, Warren SL. 1997. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA. J. Cell Biol. 136:19–28.
   PubMed Web of Science ®Google Scholar
• Kornblihtt AR. 2007. Coupling transcription and alternative splicing. Adv. Exp. Med. Biol. 623:175–189.
   PubMedGoogle Scholar
• Levine M. 2011. Paused RNA polymerase II as a developmental checkpoint. Cell 145:502–511.
   PubMed Web of Science ®Google Scholar
• Li H, et al. 2009. The sequence alignment/map format and SAM tools. Bioinformatics 25:2078–2079.
   PubMed Web of Science ®Google Scholar
• Licatalosi DD, Darnell RB. 2006. Splicing regulation in neurologic disease. Neuron 52:93–101.
   PubMed Web of Science ®Google Scholar
• Lin KT, Lu RM, Tarn WY. 2004. The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo. Mol. Cell. Biol. 24:9176–9185.
   PubMedGoogle Scholar
• Lin S, Coutinho-Mansfield G, Wang D, Pandit S, Fu XD. 2008. The splicing factor SC35 has an active role in transcriptional elongation. Nat. Struct. Mol. Biol. 15:819–826.
   PubMed Web of Science ®Google Scholar
• Listerman I, Sapra AK, Neugebauer KM. 2006. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat. Struct. Mol. Biol. 13:815–822.
   PubMed Web of Science ®Google Scholar
• Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. 2011. Epigenetics in alternative pre-mRNA splicing. Cell 144:16–26.
   PubMed Web of Science ®Google Scholar
• Makarov EM, et al. 2002. Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome. Science 298:2205–2208.
   PubMed Web of Science ®Google Scholar
• McCracken S, et al. 1997a. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357–361.
   PubMed Web of Science ®Google Scholar
• Meininghaus M, Chapman RD, Horndasch M, Eick D. 2000. Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription. J. Biol. Chem. 275:24375–24382.
   PubMedGoogle Scholar
• Misteli T, Spector DL. 1999. RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol. Cell 3:697–705.
   PubMed Web of Science ®Google Scholar
• Moore MJ, Proudfoot NJ. 2009. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136:688–700.
   PubMed Web of Science ®Google Scholar
• Morris DP, Greenleaf AL. 2000. The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 275:39935–39943.
   PubMed Web of Science ®Google Scholar
• Mortillaro MJ, et al. 1996. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. U. S. A. 93:8253–8257.
   PubMed Web of Science ®Google Scholar
• Munoz MJ, de la Mata M, Kornblihtt AR. 2010. The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem. Sci. 35:497–504.
   PubMed Web of Science ®Google Scholar
• Munoz MJ, et al. 2009. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 137:708–720.
   PubMed Web of Science ®Google Scholar
• Nasim FU, Hutchison S, Cordeau M, Chabot B. 2002. High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5′ splice site selection in support of a common looping out and repression mechanism. RNA. 8:1078–1089.
   PubMedGoogle Scholar
• Neubauer G, et al. 1998. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 20:46–50.
   PubMed Web of Science ®Google Scholar
• Nogues G, Kadener S, Cramer P, Bentley D, Kornblihtt AR. 2002. Transcriptional activators differ in their abilities to control alternative splicing. J. Biol. Chem. 277:43110–43114.
   PubMed Web of Science ®Google Scholar
• Oesterreich FC, Bieberstein N, Neugebauer KM. 2011. Pause locally, splice globally. Trends Cell. Biol. 21:328–335.
   PubMed Web of Science ®Google Scholar
• Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40:1413–1415.
   PubMed Web of Science ®Google Scholar
• Pearson JL, Robinson TJ, Munoz MJ, Kornblihtt AR, Garcia-Blanco MA. 2008. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. J. Biol. Chem. 283:7949–7961.
   PubMed Web of Science ®Google Scholar
• Rappsilber J, Ryder U, Lamond AI, Mann M. 2002. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:1231–1245.
   PubMed Web of Science ®Google Scholar
• Resnekov O, Kessler M, Aloni Y. 1989. RNA secondary structure is an integral part of the in vitro mechanism of attenuation in simian virus 40. J. Biol. Chem. 264:9953–9959.
   PubMedGoogle Scholar
• Revil T, Pelletier J, Toutant J, Cloutier A, Chabot B. 2009. Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform. J. Biol. Chem. 284:21458–21467.
   PubMed Web of Science ®Google Scholar
• Revil T, et al. 2007. Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol. 27:8431–8441.
   PubMedGoogle Scholar
• Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CW. 1998. Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res. 26:5568–5572.
   PubMed Web of Science ®Google Scholar
• Sánchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Suñé C. 2006. Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol. Cell. Biol. 26:4998–5014.
   PubMedGoogle Scholar
• Sánchez-Alvarez M, Montes M, Sánchez-Hernández N, Hernández-Munain C, SuÑé C. 2010. Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1). J. Biol. Chem. 285:15220–15233.
   PubMedGoogle Scholar
• Shkreta L, Michelle L, Toutant J, Tremblay ML, Chabot B. 2011. The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 286:331–340.
   PubMedGoogle Scholar
• Singh J, Padgett RA. 2009. Rates of in situ transcription and splicing in large human genes. Nat. Struct. Mol. Biol. 16:1128–1133.
   PubMed Web of Science ®Google Scholar
• Smith MJ, Kulkarni S, Pawson T. 2004. FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. Mol. Cell. Biol. 24:9274–9285.
   PubMedGoogle Scholar
• Suñé C, Garcia-Blanco MA. 1999. Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner. Mol. Cell. Biol. 19:4719–4728.
   PubMedGoogle Scholar
• Suñé C, et al. 1997. CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 17:6029–6039.
   PubMedGoogle Scholar
• Svotelis A, Gevry N, Gaudreau L. 2009. Chromatin immunoprecipitation in mammalian cells. Methods Mol. Biol. 543:243–251.
   PubMedGoogle Scholar
• Tous C, et al. 2011. A novel assay identifies transcript elongation roles for the Nup84 complex and RNA processing factors. EMBO J. 30:1953–1964.
   PubMedGoogle Scholar
• Wang ET, et al. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476.
   PubMed Web of Science ®Google Scholar
• Wang GS, Cooper TA. 2007. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8:749–761.
   PubMed Web of Science ®Google Scholar
• Wang KC, Cheng AL, Chuang SE, Hsu HC, Su IJ. 2000. Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions. Exp. Hematol. 28:1441–1450.
   PubMedGoogle Scholar
• Wilhelm BT, et al. 2011. Differential patterns of intronic and exonic DNA regions with respect to RNA polymerase II occupancy, nucleosome density and H3K36me3 marking in fission yeast. Genome Biol. 12:R82.
   PubMedGoogle Scholar
• Yang X, et al. 1994. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo. Proc. Natl. Acad. Sci. U. S. A. 91:6924–6928.
   PubMedGoogle Scholar
• Yuryev A, et al. 1996. The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc. Natl. Acad. Sci. U. S. A. 93:6975–6980.
   PubMed Web of Science ®Google Scholar